Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.
Clinical trial NCT03773367 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03773367
- Sponsor
- Lund University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2026-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.